文献速递关节外科

美国联邦医疗保险人群全髋关节翻修术后的并发症

Complications After Revision Total Hip Arthroplasty in the Medicare Population.
PubMed 文献 · J Arthroplasty · 2017-02-01

基于1998至2011年美国联邦医疗保险5%索赔数据,共识别64,260例初次全髋关节置换患者,其中3,555例(5.71%)接受了翻修手术。翻修术后感染率和再翻修率分别为17.3%和15.8%,高龄与静脉血栓栓塞症和死亡风险升高相关,Charlson指数较高与除脱位外各并发症风险升高相关。

要点

  • 翻修全髋关节置换术后感染率为17.3%,再翻修率为15.8%。
  • 85岁及以上患者静脉血栓栓塞症调整风险较65至69岁组高100%(P < .001),死亡调整风险高406%(P < .001)。
  • Charlson评分较高与静脉血栓栓塞症(P < .001)、感染(P < .001)、死亡(P = .002)和再翻修(P = .011)调整风险升高相关。

核心结论

  • 高龄是静脉血栓栓塞症和死亡的明确危险因素,但不是脱位、感染或再翻修的危险因素。
  • Charlson指数较高是翻修术后除脱位外每种并发症的危险因素。
  • 翻修全髋关节置换术后感染率和再翻修率较高(17.3%和15.8%),需要更多关注。

研究设计与样本

  • 研究使用1998至2011年美国联邦医疗保险5%索赔数据,样本量为64,260例初次全髋关节置换患者中接受翻修手术的3,555例(5.71%)。
  • 通过ICD-9-CM代码识别初次全髋关节置换后接受翻修的患者,评估翻修术后结局和并发症。
  • 采用多因素Cox回归评估患者人口学特征对翻修全髋关节置换患者调整后并发症风险的影响。

主要发现

  • 初次髋关节失败病因包括松动和磨损等机械性并发症(40.7%)、脱位(14.0%)和感染(11.3%)。
  • 翻修全髋关节置换术后并发症包括感染17.3%和再翻修15.8%,其后为静脉血栓栓塞症11.1%、脱位5.43%、肺栓塞3.24%和死亡2.11%。
  • 无菌性翻修术后「新发」感染率为8.13%。
  • 85岁及以上年龄组静脉血栓栓塞症调整风险较65至69岁年龄组高100%(P < .001),死亡调整风险高406%(P < .001)。
  • Charlson评分较高患者静脉血栓栓塞症(P < .001)、感染(P < .001)、死亡(P = .002)和再翻修全髋关节置换(P = .011)的调整风险较高。

临床怎么用

  • 作者指出,翻修全髋关节置换术后感染率和再翻修率较高(17.3%和15.8%),需要更多关注。
  • 作者指出,高龄是静脉血栓栓塞症和死亡的明确危险因素,但不是脱位、感染或再翻修的危险因素。
  • 作者指出,Charlson指数较高是翻修术后除脱位外每种并发症的危险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to identify the incidence and types of complications after revision total hip arthroplasty (THA) within the first year, and determine the relative risk factors for these complications and of re-revision. METHODS: The sample size of 5% Medicare claims data from 1998-2011 was studied. Primary THA patients who underwent subsequent revision were identified using ICD-9-CM codes. Outcomes and complications after revision THA were assessed. Multivariate Cox regression was used to evaluate the effect of patient demographic characteristics on the adjusted complication risk for revision THA patients. RESULTS: Of the 64,260 primary THA patients identified between 1998 and 2011, 3555 patients (5.71%) underwent revision THA. Etiology of primary hip failure included mechanical complications such as loosening and wear (40.7%), dislocation (14.0%), and infection (11.3%). Complications after revision THA included infection and redo revision, 17.3% and 15.8% followed by venous thromboembolic disease (VTE) at 11.1%, dislocation at 5.43%, PE at 3.24%, and death at 2.11%. The rate of "new" infections after an aseptic revision was 8.13%. Patients in the 85+-year-old age group had a 100% greater adjusted risk of VTE (P < .001) and 406% higher adjusted risk of death (P < .001) than those in the 65-69 years-old age group. Patients with higher Charlson scores had higher adjusted risks of VTE (P < .001), infection (P < .001), death (P = .002), and re-revision THA (P = .011). CONCLUSION: Advanced age is a clear risk factor for VTE and mortality, but not for dislocation, infection, or re-revision. Higher Charlson index was found to be a risk factor for every complication after revision except dislocation. Greater attention is required to address the high rate of infection and re-do revision after revision THA (17.3% and 15.8%).

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Badarudeen S, Shu AC, Ong KL, et al. Complications After Revision Total Hip Arthroplasty in the Medicare Population. J Arthroplasty. 2017. PMID: 28236550. doi:10.1016/j.arth.2017.01.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。